PLEN-1 - Diversity, Equity, and Inclusion in Pharmacoepidemiology – The Role of Caste in Drug Utilization, Safety, and Therapeutic Risk Management
8:30 AM – 10:00 AM US Eastern Time
PLEN-1 - Plenary Session: Diversity, Equity, and Inclusion in Pharmacoepidemiology – the Role of Caste in Drug Utilization, Safety, and Therapeutic Risk Management
Location: PLEN-1
Concurrent Session 1
10:00 AM – 11:30 AM US Eastern Time
CW03 - Concurrent Workshops 1
10:00 AM – 11:30 AM US Eastern Time
WS-03 - Big Data in Health and Bioethics: A Call for a Comprehensive, Multi-disciplinary, ISPE Position
Location: WS-03
Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
10:00 AM – 11:30 AM US Eastern Time
WS-11 - Outcome Measurements for External Comparator Arms: New Opportunities for Epidemiology Methods Application and Development
Location: WS-11
Methods in Pharmacoepidemiology
10:00 AM – 11:30 AM US Eastern Time
WS-13 - Polypharmacy: Problems and Solutions for Its Methodologic Challenges in Real-world Data
Location: WS-13
Methods in Pharmacoepidemiology
10:00 AM – 11:30 AM US Eastern Time
WS-15 - Real World Data in the Era of covid-19: The Devil in the Details. an ISPE RWE Task force/covid-19 Workgroup Symposium
Location: WS-15
Disease Epidemiology/Clinical Course
Oral Presentations Session 1
11:45 AM – 1:30 PM US Eastern Time
OP-03 - Confusion, Falls, and Fractures
11:45 AM – 1:30 PM US Eastern Time
Oral Papers: Confusion, Falls, and Fractures
Location: OP-03
11:45 AM – 1:30 PM US Eastern Time
OP-3A - Risk of Falls Following the Initiation of Antihypertensives in the Elderly: A Self-controlled Case Series in the UK
Location: OP-03
Geriatric Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-3B - Uncontrolled Pain and Risk for Depression and Behavioral Symptoms in Patients with Dementia
Location: OP-03
Geriatric Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-3C - Use of Medications with Anticholinergic and Sedative Properties and Fall-related Fractures Among Older Adults
Location: OP-03
Geriatric Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-3D - Bisphosphonate Use and Risk of Severe Acute Kidney Injury : A Self-controlled Case Series in Frail Elderly Patients in the UK
Location: OP-03
Geriatric Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-3E - Risk of Delirium Associated with Antimuscarinics in Older Adults: A Case-time-control Study
Location: OP-03
Geriatric Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-04 - COVID-19 Epidemiology: Risk Factors, Drug Exposures, and Outcomes
11:45 AM – 1:30 PM US Eastern Time
Oral Papers: COVID-19 Epidemiology: Risk Factors, Drug Exposures, and Outcomes
Location: OP-04
11:45 AM – 1:30 PM US Eastern Time
OP-4A - Severe Obesity Is a Risk Factor for Mortality in Patients with COVID-19
Location: OP-04
Disease Epidemiology/Clinical Course
11:45 AM – 1:30 PM US Eastern Time
OP-4B - Predictors of Critical Care, Mechanical Ventilation, and Mortality Among Hospitalized Patients with COVID-19 in an Electronic Health Record Database
Location: OP-04
Disease Epidemiology/Clinical Course
11:45 AM – 1:30 PM US Eastern Time
OP-4C - Utilizing the National COVID Cohort Collaborative (N3C) to Evaluate Risk of Serious Outcomes with COVID-19 Among Chronically Immunosuppressed Persons
Location: OP-04
Disease Epidemiology/Clinical Course
11:45 AM – 1:30 PM US Eastern Time
OP-4D - Incidence and Risk Factors for Covid-related Urgent Medical Visits Among US Patients Diagnosed with COVID-19 in the Outpatient Setting
Location: OP-04
Disease Epidemiology/Clinical Course
11:45 AM – 1:30 PM US Eastern Time
OP-4E - Chronic Diseases, Health Conditions and Risk of covid-19-related Hospitalization and In-hospital Mortality During the First Wave of the Epidemic in France: A Cohort Study of 66 Million People
Location: OP-04
Disease Epidemiology/Clinical Course
11:45 AM – 1:30 PM US Eastern Time
OP-4F - Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized with Non-severe COVID-19: An Observational Analysis Emulating a Target Trial
Location: OP-04
Drug Effectiveness
11:45 AM – 1:30 PM US Eastern Time
OP-06 - Drug Utilization in Pain and Musculoskeletal Conditions
11:45 AM – 1:30 PM US Eastern Time
Oral Papers: Drug Utilization in Pain and Musculoskeletal Conditions
Location: OP-06
11:45 AM – 1:30 PM US Eastern Time
OP-6A - Utilization of Non-pharmacologic Pain Therapies Among Primary Care Physicians in the United States: A Cross-sectional Survey
Location: OP-06
Drug Utilization Research
11:45 AM – 1:30 PM US Eastern Time
OP-6B - Prevalence of Osteoporosis and Its Treatment Among Women ≥50 in NHANES: 1999-2018
Location: OP-06
Drug Utilization Research
11:45 AM – 1:30 PM US Eastern Time
OP-6C - Serum Vitamin D Levels and Incident Prescription Opioid Use Among Opioid-naïve Patients
Location: OP-06
Drug Utilization Research
11:45 AM – 1:30 PM US Eastern Time
OP-6D - Discontinuation Rate of Tofacitinib Is Similar When Compared to TNF Inhibitors in Rheumatoid Arthritis Patients: Data from a Rheumatoid Arthritis Cohort
Location: OP-06
Biologics/Biosimilars
11:45 AM – 1:30 PM US Eastern Time
OP-6E - Primary Care Physicians’ Preparedness to Treat Opioid Use Disorder in the United States: A Cross-sectional Survey
Location: OP-06
Drug Utilization Research
11:45 AM – 1:30 PM US Eastern Time
OP-09 - Heterogeneity in methods
11:45 AM – 1:30 PM US Eastern Time
Oral Papers: Heterogeneity in Methods
Location: OP-09
11:45 AM – 1:30 PM US Eastern Time
OP-9A - A New Method to Estimate the Total Cohort Size for Patient Recruitment in self-controlled Case Series Study
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-9B - Sessa Empirical Estimator (SEE): A Data-driven Method for Predicting the Duration of Pharmacological Prescriptions in Secondary Data Sources
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-9C - Graphical Representation of an Array of Quantitative Bias Analysis Scenarios for Differential Outcome Misclassification
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-9D - The Performance of Different Strategies to Manage Confounding in Cardinality Matching for Medical Device Epidemiology: A Simulation Study
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-9E - Use of Linked Databases for Improved Confounding Control: Considerations for Potential Selection Bias
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-9F - A Systematic Approach Towards Missing Lab Data in Electronic Health Records: A Case Study in Non-small Cell Lung Cancer and Multiple Myeloma
Location: OP-09
Methods in Pharmacoepidemiology
11:45 AM – 1:30 PM US Eastern Time
OP-19 - Pregnancy: Wood for the trees
11:45 AM – 1:30 PM US Eastern Time
Oral Papers: Pregnancy: Wood for the Trees
Location: OP-19
11:45 AM – 1:30 PM US Eastern Time
OP-19A - Implication of Maternal Continuous Enrollment on Stillbirth Gestational Age Distributions and Maternal Characteristics in Medicaid Enrollees
Location: OP-19
Pregnancy and Lactation
11:45 AM – 1:30 PM US Eastern Time
OP-19B - Feasibility of Using Healthcare Utilization Data to Identify Neurodevelopmental Disorders for Transgenerational Pharmacoepidemiology
Location: OP-19
Pregnancy and Lactation
11:45 AM – 1:30 PM US Eastern Time
OP-19D - Validating an Optimized Live Birth Gestational Age Algorithm in a Nationwide Medicaid Sample and Quantifying the Misclassification of Exposure Due to Estimated Gestational Age
Location: OP-19
Pregnancy and Lactation
11:45 AM – 1:30 PM US Eastern Time
OP-19E - Statistical Power for Use of Tree-based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use
Location: OP-19
Pregnancy and Lactation
11:45 AM – 1:30 PM US Eastern Time
OP-19F - Use of Tree-based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use: A Propensity Score Matched Case Study
Location: OP-19
Pregnancy and Lactation
11:45 PM – 1:30 PM US Eastern Time
OP-19C - Fertility Rates in Women with Psoriasis and Psoriatic Arthritis: A Population-based Cohort Study
Location: OP-19
Pregnancy and Lactation
Oral Presentations Session 2
1:45 PM – 3:30 PM US Eastern Time
OP-14 - Opioids: A Globally Trending Topic
1:45 PM – 3:30 PM US Eastern Time
Oral Papers: Opioids: A Globally Trending Topic
Location: OP-14
1:45 PM – 3:30 PM US Eastern Time
OP-14A - Trends in Long-term Use of Prescribed Opioids in Norway 2010-2019
Location: OP-14
Drug Utilization Research
1:45 PM – 3:30 PM US Eastern Time
OP-14B - Filled Prescriptions for Opioids Among Children and Adolescents – a Nationwide Study from 2010 to 2018
Location: OP-14
Pediatric Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-14C - Trends and Outcomes of Serious Complications Associated with Non-fatal Opioid Overdoses in Ontario, Canada
Location: OP-14
Drug Utilization Research
1:45 PM – 3:30 PM US Eastern Time
OP-14D - Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Population in the United States
Location: OP-14
Drug Utilization Research
1:45 PM – 3:30 PM US Eastern Time
OP-14E - Trajectories of Pregabalin Use and Their Association with Longitudinal Changes in Opioid and Benzodiazepine Daily Dose
Location: OP-14
Drug Utilization Research
1:45 PM – 3:30 PM US Eastern Time
OP-14F - Prior Opioid Tolerance Among New Users of Transdermal Fentanyl in Taiwan, 2011-2018
Location: OP-14
Drug Utilization Research
1:45 PM – 3:30 PM US Eastern Time
OP-18 - Pregnancy: Pick-n-mix
1:45 PM – 3:30 PM US Eastern Time
Oral Papers: Pregnancy: Pick-n-mix
Location: OP-18
1:45 PM – 3:30 PM US Eastern Time
OP-18A - Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-infant Linkage Table
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-18B - Increasing Prescriptions of Misoprostol Dispensed Before Delivery in Belgium (2003-2017): Evidence from Healthcare Administrative Database
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-18C - Effects of Gadolinium-enhanced MRI Exposure During Pregnancy on Neonatal Intensive Care Unit Admission
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-18D - Proton Pump Inhibitors in Pregnancy and Risk of Preeclampsia: A Nationwide Cohort Study of 1.9 Million Pregnancies
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-18E - Validity of ICD-10 Z3A Codes for Estimating Date of Last Menstrual Period
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-18F - COVID-19 Pharmacotherapy During Pregnancy: International Registry of Coronavirus Exposure in Pregnancy (IRCEP)
Location: OP-18
Pregnancy and Lactation
1:45 PM – 3:30 PM US Eastern Time
OP-22 - The Aging Heart
1:45 PM – 3:30 PM US Eastern Time
Oral Papers: The Aging Heart
Location: OP-22
1:45 PM – 3:30 PM US Eastern Time
OP-22A - Risk of Myocardial Infarction, Stroke or Death in New Users of Intravitreal Aflibercept versus New Users of Intravitreal Ranibizumab: A Nationwide Cohort Study
Location: OP-22
Benefit-Risk Assessment, Communication, and Evaluation (BRACE)
1:45 PM – 3:30 PM US Eastern Time
OP-22C - Statin Discontinuation and Risk of Cardiovascular Events in Older People: A Population-based Cohort Study in Denmark
Location: OP-22
Geriatric Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-22D - Assessment of Co-medication Quality in Older Colorectal Cancer Patients at Hospital Discharge After Tumor Surgery and Its Associations with Chemotherapy-related Adverse Drug Reactions and 5-year Survival
Location: OP-22
Geriatric Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-22E - Comparative Risk of Cardiac Arrhythmias Associated with Acetylcholinesterase Inhibitor Use
Location: OP-22
Geriatric Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-22F - Risk of Cardiotoxicity Associated with Fluoropyrimidine-based Chemotherapy Among Older Colorectal Cancer Patients: A New User Cohort Study
Location: OP-22
Geriatric Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24 - Trials and Errors
1:45 PM – 3:30 PM US Eastern Time
Oral Papers: Trials and Errors
Location: OP-24
1:45 PM – 3:30 PM US Eastern Time
OP-24A - Using Randomized Trial Data to Estimate Effects of Complex Treatment Regimens in Real-world Patients
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24B - A Plasmode Simulation of Covariate Misclassification and Transportability
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24C - The Effect of the Anticholinergic Properties of Antidepressants on the Incidence of Dementia: A Target Trial Emulation
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24D - Stable Balancing Weights for Unanchored Matching-adjusted Indirect Comparisons and Targeting External Control Arm Estimands
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24E - Linear Mixed Model and Multistate Markov Model to Compare Changes in Clinical Measurements over Time. a Blood Pressure Example
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-24F - Rank-based Weighting for Balancing on Median Baseline Characteristics in Matching Adjusted Indirect Comparisons (MAIC)
Location: OP-24
Methods in Pharmacoepidemiology
1:45 PM – 3:30 PM US Eastern Time
OP-26 - Vaccines
1:45 PM – 3:30 PM US Eastern Time
Oral Papers: Vaccines
Location: OP-26
1:45 PM – 3:30 PM US Eastern Time
OP-26A - Evaluation of the Potential Confounding Effect of Shingles on the Risk of Guillain-barré Syndrome After Vaccination with the Recombinant Zoster Vaccine
Location: OP-26
Vaccines
1:45 PM – 3:30 PM US Eastern Time
OP-26C - Sensitivity Analysis of Design Choices for Estimating Incidence Rates of Adverse Events of Special Interest in Vaccine Safety
Location: OP-26
Vaccines
1:45 PM – 3:30 PM US Eastern Time
OP-26D - Effectiveness of Influenza Vaccination in Healthy Children: A Population-based Investigation
Location: OP-26
Vaccines
1:45 PM – 3:30 PM US Eastern Time
OP-26E - Background Incidence Rates of Adverse Events of Special Interest for COVID-19 Vaccine Monitoring
Location: OP-26
Vaccines
1:45 PM – 3:30 PM US Eastern Time
OP-26F - Vaccination and Acute Flares in Multiple Sclerosis: A Nationwide Case-crossover Study Using the French SNDS Health Care Databases
Location: OP-26
Vaccines
Concurrent Session 2
3:30 PM – 5:00 PM US Eastern Time
CW04 - Concurrent Workshops 2
3:30 PM – 5:00 PM US Eastern Time
WS-04 - COVID-19 Confidential: Enabling Trust in COVID-19 Research with Fit for Purpose Real-world Data
Location: WS-04
Methods in Pharmacoepidemiology
3:30 PM – 5:00 PM US Eastern Time
WS-05 - Drug Utilization Research in Africa: Challenges and Potential Solutions
Location: WS-05
Drug Utilization Research
3:30 PM – 5:00 PM US Eastern Time
WS-19 - Triangulating the Truth: State-of-the-art Sensitivity Analyses for Observational Research
Location: WS-19
Methods in Pharmacoepidemiology
Lightning Session 1
5:30 PM – 6:30 PM US Eastern Time
L-1 - Lightning Presentations Session 1
5:30 PM – 6:30 PM US Eastern Time
Lightning Presentations Session 1
Location: L-1
5:30 PM – 6:30 PM US Eastern Time
L-1 - Lightning Session 1
5:30 PM – 6:30 PM US Eastern Time
L-1A - Use of Remdesivir for COVID-19 in the Real World: An Analysis of US Electronic Medical Records
Location: L-1
Disease Epidemiology/Clinical Course
5:30 PM – 6:30 PM US Eastern Time
L-1B - Comparing Outcomes in Trial-eligible vs Real-world COVID-19 Patients: The Case of Invasive Mechanical Ventilation
Location: L-1
Disease Epidemiology/Clinical Course
5:30 PM – 6:30 PM US Eastern Time
L-1C - Outpatient-identified COVID-19 and Subsequent Hospitalized Thrombotic Events
Location: L-1
Disease Epidemiology/Clinical Course
5:30 PM – 6:30 PM US Eastern Time
L-1D - Patients Tell All: Using a Direct-to-patient Community Registry to Understand Patient Burden of COVID-19
Location: L-1
Disease Epidemiology/Clinical Course
5:30 PM – 6:30 PM US Eastern Time
L-1E - Marginal Structural Models with Latent Class Growth Modeling of Time-varying Treatment
Location: L-1
Methods in Pharmacoepidemiology
5:30 PM – 6:30 PM US Eastern Time
L-1F - Residual Bias and Indirect Covariate Balance in an Applied Comparison of Large-scale Propensity Score and Cardinality Matching
Location: L-1
Methods in Pharmacoepidemiology
5:30 PM – 6:30 PM US Eastern Time
L-1G - Characterizing Imbalance in the Tails of the Propensity Score Distribution
Location: L-1
Methods in Pharmacoepidemiology
5:30 PM – 6:30 PM US Eastern Time
L-1H - High-dimensional Propensity Score Approaches in Stata Using the Hdps Suite of Commands
Location: L-1
Methods in Pharmacoepidemiology
5:30 PM – 6:30 PM US Eastern Time
L-1J - Patterns of Antibiotic Prescription Among Adult Outpatients in Italy
Location: L-1
Drug Utilization Research
5:30 PM – 6:30 PM US Eastern Time
L-1K - Determinants of Antimalarial Prescription Patterns Among Health Care Providers in Public Health Facilities in Uasin Gishu County, Kenya
Location: L-1
Drug Utilization Research
5:30 PM – 6:30 PM US Eastern Time
L-1L - Co-utilization of Opioids and Non-benzodiazepine Sedative Hypnotics in U.S. Ambulatory Care Visits, 2006 – 2016
Location: L-1
Drug Utilization Research
5:30 PM – 6:30 PM US Eastern Time
L-1M - Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network
Location: L-1
Drug Utilization Research
5:30 PM – 6:30 PM US Eastern Time
L-1N - Comparative Effectiveness of Bevacizumab versus Cetuximab in Patients with Metastatic Colorectal Cancer
Location: L-1
Drug Effectiveness
5:30 PM – 6:30 PM US Eastern Time
L-1P - Efficacy-effectiveness Gap for Standard First-line Treatment Of
metastatic Non-small Cell Lung Cancer Among Patients with Barriers to Care
Location: L-1
Drug Effectiveness
5:30 PM – 6:30 PM US Eastern Time
L-1Q - Acute Kidney Injury in Patients with Atrial Fibrillation Treated with Rivaroxaban or Warfarin: A Population-based Study in the United Kingdom
Location: L-1
Drug Effectiveness
5:30 PM – 6:30 PM US Eastern Time
L-1R - Long-acting Insulin Analogs versus Intermediate-acting Insulin and the Risk of Major Adverse Cardiovascular Events Among Patients with Type 2 Diabetes in the United Kingdom
Location: L-1
Drug Effectiveness
Lightning Session 2
6:30 PM – 7:30 PM US Eastern Time
L-2 - Lightning Presentations Session 2
6:30 PM – 7:30 PM US Eastern Time
Lightning Presentations Session 2
Location: L-2
6:30 PM – 7:30 PM US Eastern Time
L-2 - Lightning Session 2
6:30 PM – 7:30 PM US Eastern Time
L-2A - Changes in Purchases of Intensive Care Medicines During COVID-19 in Developed vs. Developing Countries
Location: L-2
Drug Utilization Research
6:30 PM – 7:30 PM US Eastern Time
L-2B - Collider Bias in COVID-19 Studies: Explaining the Smoking Paradox
Location: L-2
Methods in Pharmacoepidemiology
6:30 PM – 7:30 PM US Eastern Time
L-2C - The Prevalence of Hyperkalemia and Associated Clinical Characteristics and Outcomes Among Hospitalized COVID-19 Patients
Location: L-2
Health Economics/Outcomes Research
6:30 PM – 7:30 PM US Eastern Time
L-2D - Off-label Use of Potential Pharmacological Treatment for COVID-19: An Intensive Pharmacovigilance in Peru
Location: L-2
Pharmacovigilance
6:30 PM – 7:30 PM US Eastern Time
L-2E - Identification and Characterization of Fistulizing Crohn’s Disease in EHR Using Structured and Unstructured Data
Location: L-2
Methods in Pharmacoepidemiology
6:30 PM – 7:30 PM US Eastern Time
L-2F - Validation of Diagnosis Algorithms for Melanoma and Nonmelanoma Skin Cancer Among Patients with Parkinson’s Disease in the United States Medicare Database
Location: L-2
Methods in Pharmacoepidemiology
6:30 PM – 7:30 PM US Eastern Time
L-2G - An Algorithm to Derive Response and Progression Status Based on International Myeloma Working Group Response Criteria for Patients with Multiple Myeloma in a Real-world Database
Location: L-2
Methods in Pharmacoepidemiology
6:30 PM – 7:30 PM US Eastern Time
L-2H - Identification of Serostatus in Rheumatoid Arthritis Using ICD-10 Diagnosis Codes
Location: L-2
Disease Epidemiology/Clinical Course
6:30 PM – 7:30 PM US Eastern Time
L-2J - Cost-utility of Nivolumab for Treatment of Head and Neck Cancer from a Brazilian Public Health System Perspective
Location: L-2
Health Economics/Outcomes Research
6:30 PM – 7:30 PM US Eastern Time
L-2K - SGLT2 Inhibitors vs. GLP-1 Agonists: Comparative Progression of Renal Disease
Location: L-2
Health Economics/Outcomes Research
6:30 PM – 7:30 PM US Eastern Time
L-2L - Comparison of Medication Adherence Between Initiators of a Multi-drug Dispensing System & Users of Retail Pharmacy
Location: L-2
Health Economics/Outcomes Research
6:30 PM – 7:30 PM US Eastern Time
L-2M - Effects of Initiating a Multi-dose Drug Dispensing System on Medication Adherence
Location: L-2
Health Economics/Outcomes Research
6:30 PM – 7:30 PM US Eastern Time
L-2N - Prevalence of Myxoid /round Cell Liposarcoma (MRCLS) Among Children and Adults in the United States
Location: L-2
Disease Epidemiology/Clinical Course
6:30 PM – 7:30 PM US Eastern Time
L-2P - Atopic Eczema Associated Fracture Risk and Oral Corticosteroids: A Population-based Cohort Study
Location: L-2
Disease Epidemiology/Clinical Course
6:30 PM – 7:30 PM US Eastern Time
L-2Q - Trends in Sexually Transmitted Infections in the United States Ambulatory Care Clinics from 2005-2016
Location: L-2
Disease Epidemiology/Clinical Course
6:30 PM – 7:30 PM US Eastern Time
L-2R - Chemotherapy Relative Dose Intensity, Overall Survival, and Hematologic Toxicity in Solid-tumor Cancer Patients: A Literature Review and Meta-analysis
Location: L-2
Disease Epidemiology/Clinical Course
Plenary 1 - Repeat
8:00 PM – 9:30 PM US Eastern Time
PLEN-1B - REPEAT: Diversity, Equity, and Inclusion in Pharmacoepidemiology – The Role of Caste in Drug Utilization, Safety, and Therapeutic Risk Management
8:00 PM – 9:30 PM US Eastern Time
PLEN-1B - REPEAT: Diversity, Equity, and Inclusion in Pharmacoepidemiology – the Role of Caste in Drug Utilization, Safety, and Therapeutic Risk Management
